Genome-wide association studies show that cholesteryl ester transfer protein (CETP) single nucleotide polymorphisms (SNPs) are more strongly associated with HDL-C concentrations than any other loci across the genome. However, gene-environment interactions for clinical applications are still largely unknown. We studied gene-environment interactions between CETP SNPs and dietary fat intake, adherence to the Mediterranean diet, alcohol consumption, smoking, obesity and diabetes on HDL-C in 4,210 high cardiovascular risk subjects from a Mediterranean population. We focused on the -4,502C>T and the TaqIB SNPs, in partial linkage disequilibrium (D´:0.88;P<0.001). They were independently associated with higher HDL-C (P<0.001), this clinically relevant association being greater when their diplotype was considered (14% higher in TT/B2B2 versus CC/B1B1). No gene-gene interaction was observed. We also analyzed the association of these SNPs with blood pressure and no clinically relevant associations were detected. No statistically significant interactions of these SNPs with obesity, diabetes and smoking in determining HDL-C concentrations were found. Likewise, alcohol, dietary fat and adherence to the Mediterranean diet did not statistically interact with the CETP variants (independently or as diplotype) in determining HDL-C. In conclusion, the strong association of the CETP SNPs and HDL-C was not statistically modified by diet or by the other environmental factors.
INTRODUCTION
Results from recent genome-wide association studies (GWAs) carried out in several populations, in which markers are studied in all chromosomes, have allowed us to know that cholesteryl ester transfer protein (CETP) single nucleotide polymorphisms (SNPs) are associated with HDL-C more strongly than any other loci across the genome [1] [2] [3] [4] . Hence for example, in the work of Kathiresan et al [3] , in which 11 new loci related to lipid metabolism were identified, the locus most associated with HDL-C concentrations was the CETP gene (P value of 4 x 10 -75 ). The second most-associated locus was the LPL gene (P value of 2 x10 -34 ).
Still smaller were associations obtained for the newly discovered loci associated with HDL-C (P values between 10 -8 and 10 -14 ). This highlights the importance of the CETP gene variation as a potential genetic marker for future clinical applications related with HDL-C. In addition, the current controversy involving the new drugs (i.e., torcetrapib) designed to inhibit CETP activity and to increase HDL-C concentrations to decrease cardiovascular risk [5] [6] [7] [8] , have increased interest in this gene for clinical applications.
It is well known that certain variants in the CETP gene are associated with decreased plasma CETP protein activity and protein levels, thereby, resulting in greater HDL-C concentrations [9] [10] [11] . Among them, the TaqIB SNP (rs708272) has been the most widely studied. Meta-analyses have shown that carriers of the B2 allele, associated with lower CETP, have higher HDL-C concentrations than B1B1 homozygotes [12, 13] . However, given that this SNP is located in an intron, a number of studies [10, [14] [15] [16] have been carried out to find the possible functional variant with which this SNP would be in linkage disequilibrium (LD). The study of Thompson et al [16] has been the most comprehensive as a dense genotyping of CETP and regions up to 15 kb on either side of the gene on >2,000 individuals was undertaken. These that have analyzed gene-environmental interactions, a lack of consistency is observed. Some studies have reported that alcohol consumption statistically interacts with the TaqIB SNP and modifies its effects on HDL-C concentrations [17] [18] [19] , whereas others have not supported this interaction [20] [21] [22] . Likewise, although there is one observational study [23] in which a statistically significant interaction between the TaqIB-SNP and fat intake was found, those results have not been replicated [24] . Moreover, some intervention studies did not demonstrate TaqIB-fat interactions [25, 26] . Therefore, our aims were: a) To estimate the impact (additive or interactive effects) between the TaqIB and the -4,502C>T promoter SNP on HDL-C and related parameters including blood pressure in a large high cardiovascular risk Mediterranean population; b) To study gene-environment interactions between these SNPs and lifestyle factors (focusing on alcohol consumption, fat intake, adherence to Mediterranean diet and smoking) as well as with obesity and diabetes in determining HDL-C concentrations.
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METHODS
Subjects
We included the first 4,210 participants (1,840 men and 2,370 women) entering the PREDIMED (PREvención con DIeta MEDiterránea) Study from whom DNA was isolated, the TaqIB and the -4,502C>T CETP promoter SNP determined and had valid data for the main variables analyzed.
The PREDIMED study is a multi-center clinical trial aimed at assessing the effects of the Mediterranean Diet on the primary prevention of cardiovascular disease. Details of this study have been reported elsewhere [27] . [27] . The Institutional Review Board of each participating center approved the study protocol, and all participants provided written informed consent.
Demographic, clinical, anthropometric and dietary measurements
The baseline examination included assessment of standard cardiovascular risk factors, medication use, socio-demographic factors and lifestyle variables, as previously detailed [27] . Food consumption was determined by a validated semi-quantitative 137-item food frequency questionnaire (FFQ) also including consumption of alcoholic drinks [28] . Energy and nutrient intake were calculated from Spanish food composition tables [29] . This FFQ was also specifically validated in a sample of this population [30] . The results of this validation study showed a very good reproducibility for food groups, energy and nutrient intake explored by intraclass correlation coefficients that ranged from 0.63 to 0.90, which is comparable to other FFQs used in association studies between diet and cardiovascular diseases [31, 32] . We calculated alcohol intake (in g/d) for each individual on the basis of the type and amount of alcoholic beverages consumed. Three groups were defined according to the reported daily intake of alcohol: no intake (0 g/d), moderate intake (<26.4 g/d for men and <13.2 g/d for women), and high intake (26.4 g/d for men and 13.2 g/d for women). These gram amounts correspond to 1 drink/d for women and 2 drinks/d, for men [33] . The baseline examination also included the administration of a validated 14-item questionnaire indicating the degree of adherence to the traditional Mediterranean diet [27] . Values of 0 or 1 were assigned to each of 14 dietary components. The greater score obtained from the questionnaire, the greater the adherence to the population have shown a good performance of this scale [34] . Physical activity was estimated by the Minnesota Leisure Time Physical Activity, validated for its use in Spanish subjects [35] . The reliability of this questionnaire following its repeated administration in the pilot study [27] , was calculated using the Spearman correlation coefficient (rho) for total physical activity at baseline and 3 months, and was high (rho=0.83; P<0.001).
Weight and height were measured with calibrated scales and a wall-mounted stadiometer, respectively. BMI was calculated as weight in kilograms divided by the square of height in meters. Trained personnel measured blood pressure in triplicate with a validated semi-automatic sphygmomanometer (Omron HEM-705CP, The Netherlands) in a seated position after a 5-min rest.
Biochemical determinations, DNA extraction and genotyping
At baseline, blood samples were obtained for each participant after an overnight fast and were frozen at -80ºC and shipped to central laboratories for analyses. Fasting glucose, total cholesterol, triglycerides, HDL-C and LDL-C were determined as previously reported [27] . Plasma glucose was analyzed by the glucose-oxidase method; triglycerides and total cholesterol were measured using standard enzymatic procedures; and HDL-C after precipitation with phosphotungstic acid and magnesium chloride. LDL-C concentrations were estimated with the equation of Friedewald et al, whenever triglycerides were <400 mg/dL.
Genomic DNA was extracted from buffy-coat with the MagNaPure LC DNA Isolation Kit (Roche Diagnostics, Mannheim, Germany). We analyzed the TaqIB SNP (rs708272) using the polymerase chain reaction-restriction fragment length polymorphism method described previously [20] . The -4,502C>T promoter SNP (rs183130), was genotyped on a 7900HT
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Sequence Detection System (Applied Biosystems, FosterCity, CA, USA) using a fluorescent allelic discrimination TaqManTM assay. For quality control purposes, 10% of randomly selected samples were genotyped a second time. There were no discrepancies between the two results.
Statistical Analyses
Chi-square tests were used to test differences between observed and expected genotype frequencies, assuming Hardy-Weinberg equilibrium, and to test differences in percentages. The LD between the CETP SNPs was assessed with the Haploview software package and Lewontin's disequilibrium coefficient D´ was estimated. A combined diplotype variable was created taking 3 categories into consideration for the -4,502C>T and the TaqIB SNP: 1) Pure homozygotes for the C-B1 (C-B1/C-B1) diplotye; 2) pure homozygotes for the T-B2 (T-B2/TB2) diplotye; and 3) a mixed category including any other combination of diplotypes (as we first carried out an exploratory analysis and no relevant differences among them were found). Triglycerides and alcohol intake were log-transformed for the statistical analyses. T and ANOVA tests were applied to compare crude means. Multivariate adjustments for continuous variables were carried out by analysis of covariance. Models were adjusted for age, gender, BMI, diabetes, tobacco smoking, alcohol consumption, physical activity, education and medications (lipid-lowering and antihypertensive drugs). The homogeneity of the effects by gender was also statistically tested.
To test the interaction between the CETP gene variants and type 2 diabetes, obesity (BMI>=30 Kg/m 2 ), tobacco smoking, alcohol consumption, fat intake variables or adherence to Mediterranean diet, separated multivariate regression models including the corresponding main effects and interaction terms in addition to the above variables and total energy intake to control for potential confounders, were fitted. Stratified analyses were also carried out. Total fat intake, Multivariate logistic regression models including the control for the different environmental factors were fitted. Statistical analyses were performed with the SPSS package, version 15.0 (SPSS, Chicago, IL). All tests were two-tailed and P values <0.05 were first considered statistically significant. However, taking into account that multiple comparisons have been carried out, a corrected P value of <0.01 was also considered to minimize the Type I error that could derive from this. Table 1 Table 2 details BMI, plasma lipid concentrations, fasting glucose and blood pressure according to the CETP TaqIB SNP, the -4,502C>T SNP and their diplotypic variable at baseline.
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RESULTS
Participant´s characteristics
Relationships between CETP variants and continuous biochemical and clinical parameters
There were no differences in the mean age of each genetic group, all being 67+/-6 years. No association between BMI, fasting glucose, total cholesterol or LDL-C concentrations and the genetic variables was observed. However, a highly significant, and clinically relevant, association between the two CETP SNPs and HDL-C concentrations was found. In the regression Regarding the controversial association between CETP activity inhibition and greater blood pressure [7] , no association of the SNPs was found with systolic blood pressure.
Nevertheless, a low, statistically significant (P<0.01), but not clinically relevant, association was found for the diplotype with diastolic blood pressure. However, this association did not present any linear trend (the lowest values were detected in the heterozygote group). If, instead of these continuous variables, the association of CETP SNPs with hypertension is studied, no significant results are found in any of the three genetic variables. Thus, for the diplotye variable, the prevalence of hypertension was 80.4% in the C-B1/C-B1, 79.8% in the intermediate diplotyes,
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and 80.3% in the B2/T-B2 subjects (P=0.906).
Gene-environment interactions between the CETP SNPs and lifestyle variables
Given that HDL-C was the phenotype showing the highest significant association with the genetic variants studied, we then analyzed whether that association was modulated by environmental factors and clinical conditions. Table 3 . No statistical significant interactions were found, and a great homogeneity in the genetic effects of the CETP variants being observed in the different strata considered.
Delving deeper into the study of the interaction between the two polymorphisms and diet, Having undertaken the analysis of these interactions on both the group of individuals on lipid-lowering drugs and on those who did not take them, no statistically significant interactions were observed in either of the sub-groups and the relationships were similar (point estimates differing by less than 10% and the confidence intervals overlapping). Supplementary Table 2 shows the results of the interaction analysis with the main environmental variables and clinical conditions determining HDL-C depending on CETP diplotype in subjects not taking lipidlowering medications.
Association between the CETP variants and risk of having low HDL-C
Given the homogeneity of the effect of the variations in the CETP gene on HDL-C concentrations, we assessed their impact in determining defined low HDL-C concentrations [34] mg/dL) of HDL-C in subjects carrying two copies of the variant diplotye vs wild-type are detected. Considering that a 1% increase in HDL-C has been associated with a 2-3% reduction in cardiovascular morbidity and mortality [38, 39] , and that our study involves a high-risk population, these CETP SNPs could have a relevant role in atherogenesis. Comparing the effects with other populations, we found that the TaqIB SNP was similar to that described [13] , whereas the effect of the -4,502C>T SNP in our study appears to be slightly higher than that reported by Thompson et al [16] . The other study that analyzed the association of the -4,502C>T SNP with HDL-C [40] did not provide mean values, but this SNP exhibited the most significant association.
The association of CETP SNPs with blood pressure has not been routinely examined in prior studies, and it was not included as a phenotype in the prior meta-analyses [12,13]. However, a recent meta-analysis [38] has been focused on it given the controversy arising from clinical trials with torcetrapib, in which an increase in blood pressure was observed [7, 41] . In our study no association of the CETP variants with systolic blood pressure was found. Nevertheless, some statistically significant associations were observed with diastolic blood pressure. However, this association was small, not clinically relevant and did not follow a gene-dosage effect. In addition, bearing in mind the results of no association of the CETP SNPs with systolic or diastolic blood pressure in a recent meta-analysis [41] , the association observed in our study with diastolic blood pressure may be produced at random. In this regard, functional studies pointed out that torcetrapib induces aldosterone and cortisol synthesis by an intracellular calcium-mediated mechanism that is independent of CETP inhibition [42] , thus other CETP inhibiting interventions could still increase HDL-C without having off-target effects on blood pressure [43].
In the current study, we assessed for the first time gene-environment interactions of the -4,502C>T SNP on HDL-C concentrations. Initial studies of interactions were mainly focused on the TaqIB SNP. A classic example is the study of the Fumeron et al [17] in French males in which a gene-alcohol interaction was described in such a way that the effect of B2 on HDL-C concentrations was absent in subjects drinking < 25 g/d of alcohol but increased at higher levels. Therefore, to increase HDL-C concentrations in subjects with the non-favourable CETP genotypes, it is necessary to consider "biological" [46] gene-diet interactions instead of "statistical" gene-diet interactions because no genetic determinism was found (HDL-C concentrations were different in subjects with the same genotype that differed in environmental factors or clinical conditions. For example, HDL-C concentrations were higher in B1B1 nondiabetic subjects than in B2B2 diabetic subjects).
One of the strengths of our study is that it was initially designed to analyze gene-environment interactions and we have measured genetic, anthropometric, clinical, biochemical and lifestyle variables, including diet, in a large sample to compare the magnitude of the effects and the potential interactions. Despite the fact that some other studies have described statistically significant interactions, we have found no statistically significant interaction between any of the genetic variants studied (the TaqIB SNP, the -4,502C>T SNP or their diplotye) and these factors in determining HDL-C. One of the reasons, and also a strength of our study, that may have contributed to this is our large sample size. This apparent paradox can be easily explained by bearing in mind that if modifications of the effects in the different strata considered do not really exist, a study of greater sample size provides greater stability in the measurements, minimizing the probability of wide differences being found randomly in means between strata. On the other hand, in a study of smaller sample size, although its statistical power for detecting true modifications of the effect is lesser, the instability of the measurements is greater, increasing the probability of wrongly detecting statistically significant interactions. 1: Low HDL-C (<40 mg/dL in men and <50 mg/dL in women). N=1095 subjects with low HDL-C and 3115, non-low.
Multivariate logistic regression models including the CETP diplotype, diabetes, obesity, hypertension, smoking, alcohol and total fat were additionally adjusted for sex, age, physical activity, education and medications.
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